ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1846

Cutaneous and Visceral Fibrosis Induced By Endothelial Cell-Specific Constitutive Activation of TGF-β1 Signaling in Mice

Peter J. Wermuth, Kellan R. Carney, Fabian A. Mendoza, Sonsoles Piera-Velazquez and Sergio A. Jimenez, Jefferson Institute of Molecular Medicine, Division of Connective Tissue Diseases and Scleroderma Center, Thomas Jefferson University, Philadelphia, PA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: fibrosis, Mouse model, systemic sclerosis and transforming growth factor

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics - Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Microvascular damage is an early event in Systemic Sclerosis (SSc) pathogenesis and may represent the initiating stimulus for the subsequent establishment and progression of the fibrotic process. Extensive experimental evidence shows the increased expression and production of the pleiotropic growth factor transforming growth factor-β (TGF-β) and of TGF-β-regulated genes in SSc patient tissues however, the effects of cell-specific TGF-β expression in endothelial cells have not been studied. The purpose of these studies was to generate a transgenic mouse strain characterized by the inducible expression of TGF-β signaling specifically in cells of endothelial lineage. The novel transgenic mouse strain (TGFβca-Cdh5 Cre) would be utilized for the evaluation of the effect of upregulated TGF-β expression specifically in the microvasculature and to examine directly the role of endothelial cell activation in the development of tissue fibrosis.

Methods: A transgenic mouse strain carrying an inducible constitutively active TGF-β receptor I (TBRIca) allele was intercrossed with a second mouse strain (B6.Cg-Tg(Cdh5-cre/ERT2)Mlia/J) carrying a Cre-ERT2 expression cassette controlled by the endothelial cell-specific Cdh5 promoter. A functional TBRIcaallele is generated by intraperitoneal injection of 4-OH tamoxifen, yielding constitutive and unrestricted TGF-β signaling in all cells of endothelial lineage. The results of the intercross were evaluated by histopathologic staining of skin and visceral tissues, by immunhistochemical staining of lung for α-smooth muscle actin and von Willebrand factor, measurement of tissue hydroxyproline content, and by evaluation of the expression of genes associated with tissue fibrosis, myofibroblast differentiation and TGF-β signaling.

Results: Constitutive TGFβ-1 signaling in endothelial lineage cells resulted in severe and progressive cutaneous and visceral tissue fibrosis compared to saline-injected control mice. Increased collagen deposition and microvascular fibroproliferative changes in the dermis, lungs, myocardium, liver, and kidney were observed by histopathological analysis of these tissues. A 2.2 fold increase in hydroxyproline content of the skin and a 2.8 fold increase in the lung was observed. Increased expression of several profibrotic genes associated with tissue fibrosis and the transdifferentiation and activation of myofibroblasts was demonstrated in total RNA isolated from skin and lungs of these animals.

Conclusion: A remarkable observation was the development of extensive fibrosis in the skin, lungs and other organs in mice with constitutive endothelial cell-specific activation of TGF-β-signaling. Alterations resembling the microvascular pathology characteristic of human SSc were also observed. These results render this transgenic mouse strain a valuable model for SSc as they reproduce the typical cutaneous and visceral tissue fibrosis and severe fibroproliferative microvascular alterations found in SSc. These results also provide new information about the pathogenesis of tissue fibrosis in response to the effect of increased TGF-β expression specifically in cells of endothelial origin.


Disclosure: P. J. Wermuth, None; K. R. Carney, None; F. A. Mendoza, None; S. Piera-Velazquez, None; S. A. Jimenez, None.

To cite this abstract in AMA style:

Wermuth PJ, Carney KR, Mendoza FA, Piera-Velazquez S, Jimenez SA. Cutaneous and Visceral Fibrosis Induced By Endothelial Cell-Specific Constitutive Activation of TGF-β1 Signaling in Mice [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/cutaneous-and-visceral-fibrosis-induced-by-endothelial-cell-specific-constitutive-activation-of-tgf-%ce%b21-signaling-in-mice/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cutaneous-and-visceral-fibrosis-induced-by-endothelial-cell-specific-constitutive-activation-of-tgf-%ce%b21-signaling-in-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology